Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (1): 9-19.doi: 10.3736/jcim20090102

• Systematic Review • Previous Articles     Next Articles

Tanreqing Injection for community-acquired pneumonia: A systematic review of randomized evidence

Hong-li Jiang,  Bing Mao, Yun-qing Zhong , Hong-mei Yang , Juan-juan Fu    

  1. Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China
  • Received:2008-07-30 Accepted:2008-09-09 Online:2009-01-20 Published:2009-01-15


To evaluate the efficacy and safety of Tanreqing Injection, a compound traditional Chinese herbal medicine, for community-acquired pneumonia.

Literatures about randomized controlled trials of Tanreqing Injection for community-acquired pneumonia were reviewed. Related literatures were selected and analyzed according to different treatment strategies of the trials. The methodological quality of the trials was assessed by the Jadad scale, and evaluation was performed.

Twelve randomized controlled trials meeting the inclusion criteria were selected and reviewed. As Tanreqing combined group (Tanreqing Injection plus antibiotics and basic therapy) was compared with antibiotics group (antibiotics plus basic therapy), the meta-analysis indicated that the relative risk (RR) for the total cure rate was 1.51, and 95% confidence interval (CI) was [1.29, 1.77]; RR for the total obvious effect rate was 1.31, and 95% CI was [1.20,1.43]; RR for the effective rate was 1.17, and 95% CI was [1.11, 1.23]. The weighted mean difference (WMD) in disappearance time of fever between the two groups was –1.24, and 95% CI was [–1.71, –0.76]. The RR values between the two groups for the total obvious effect rate of cough and expectoration were 1.42 and 1.27, and 95% CIs were [1.16, 1.74] and [1.04, 1.55] respectively. The RR values between the two groups in absorption of chest X-ray shadow and neutrophil number were 1.19, 1.10 and 95% CIs were [1.09, 1.30], [1.03, 1.17] respectively. The differences were all statistically significant. Serious systematic adverse reactions had not been reported in the trials.

The effect of combined therapy with Tanreqing Injection plus antibiotics and basic therapy is better than that of antibiotics plus basic therapy. Tanreqing Injection can improve the symptoms of cough and expectoration, shorten the fever time and facilitate the absorption of chest X-ray shadow, without any significant adverse reactions. However, further high-quality trials are needed.

Key words: Tanreqing Injection, Community-acquired pneumonia, Randomized controlled trials, Systematic review, Meta-analysis

Figure 1

Study selection process for randomized controlled trials"

Table 1

Clinical characteristics of enrolled trials"

Study Intervention Cases (male/female) Duration
Age (years)
Treatment group Control group Treatment group Control group Treatment group Control group
Feng et al[8] Tanreqing and antibiotics Antibiotics 29 (18/11) 27 (17/10) 10-14 46.22±12.26 45.25±13.04
Jiu[9] Tanreqing and azithromycin Azithromycin 34 (18/16) 34 (19/15) 7-14 18-75 20-70
Wen et al[10] Tanreqing and cefuroxime Cefuroxime 50 (31/19) 49 (27/22) 10 22-74 23-72
Chen et al [11] Tanreqing and antibiotics Antibiotics 32 (18/14) 32 (17/15) 10 72.52±9.31 71.94±9.65
Qu[12] Tanreqing and antibiotics Antibiotics 40 (24/16) 40 (22/18) 14 23-74 21-75
Zhang[13] Tanreqing and levofloxacin Levofloxacin 48 (28/20) 50 (26/24) 10 69.00±13.00 72.00±14.00
Liu[14] Tanreqing and levofloxacin Levofloxacin 20 (12/8) 20 (10/10) 7 52.15±12.75 54.00±11.35
Liu et al[15] Tanreqing and antibiotics Antibiotics 50 (28/22) 50 (29/21) 7 42.35±12.36 41.67±11.28
Yang[16] Tanreqing and cefoperazone Cefoperazone 42 (25/17) 40 (24/16) 10 72.00±8.40 72.00±8.70
Song et al[17] Tanreqing and azithromycin Azithromycin 24 (14/10) 24 (12/12) 7 35-80 33-79
Li et al[18] Tanreqing, azithromycin
and cefuroxime
and cefuroxime
50 (30/20) 49 (31/18) 12 71.60±13.20 72.20±12.80
Yan et al[19] Tanreqing Clindamycin 20 (13/7) 20 (11/9) 28 73.54±1.33 70.71±2.12

Table 2

Methodological quality of enrolled trials"

Study Randomization Allocation concealment Blinding Withdrawls Jadad score ITT Baseline
Feng et al[8] Not mentioned No No No 1 No Similar
Jiu[9] Not mentioned No No No 1 No Similar
Wen et al[10] Not mentioned No No No 1 No P>0.05
Chen et al[11] Not mentioned No No No 1 No P>0.05
Qu[12] Not mentioned No No No 1 No P>0.05
Zhang[13] Not mentioned No No No 1 No P>0.05
Liu[14] Not mentioned No No No 1 No P>0.05
Liu et al[15] Random-number table No No No 2 No P>0.05
Yang[16] Not mentioned No No No 1 No P>0.05
Song et al[17] Not mentioned No No No 1 No P>0.05
Li et al[18] Quasi-randomized No No No 1 No P>0.05
Yan et al[19] Not mentioned No No Yes 2 No P>0.05

Figure 2

Total cure rates in Tanreqing combined group and antibiotics group"

Figure 3

Total obvious effect rates in Tanreqing combined group and antibiotics group"

Figure 4

Total effective rates in Tanreqing combined group and antibiotics group"

Figure 5

Disappearance time of fever in Tanreqing combined group and antibiotics group"

Figure 6

Total obvious effect rates of cough and expectoration in Tanreqing combined and antibiotics group"

Figure 7

Absorption of chest X-ray shadow of Tanreqing combined group and antibiotics group"

Figure 8

Improvement of blood routine test in Tanreqing combined group and antibiotics group"

Figure 9

Adverse reactions in Tanreqing combined group and antibiotics group"

Figure 10

Funnel plot for total cure rate"

Figure 11

Sensitivity analysis of the total cure rates in Tanreqing combined group and antibiotics group"

[1] Ramirez JA . Community-acquired pneumonia in adults[J]. Prim Care, 2003,30(1):155-171
doi: 10.1016/S0095-4543(02)00076-3
[2] Niederman MS, Ahmed QA . Community-acquired pneumonia in elderly patients[J]. Clin Geriatr Med, 2003,19(1):101-120
doi: 10.1016/S0749-0690(02)00061-7
[3] Arnold FW, Ramirez JA, McDonald LC, Xia EL .Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment[J]. Chest, 2003,124(1):121-124
doi: 10.1378/chest.124.1.121
[4] Li W, Mao B, Wang G, Wang L, Chang J, Zhang Y, Wan MH, Guo J . A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion[J]. J Chin Integr Med, 2008,6(8):799-805
李文, 毛兵, 王刚, 王蕾, 常静, 张颖, 万美华, 郭佳 . 从气道炎症和气道黏液高分泌研究清热化痰法治疗慢性阻塞性肺疾病急性加重期痰热阻肺证的机制[J]. 中西医结合学报, 2008,6(8):799-805
[5] Zheng XY. Guiding principles for clinical research on new drugs of traditional Chinese medicine(Trial imple-mentation)[M]. Beijing: China Medical-Pharmaceutical Science & Technology Publishing House,2002: 58
郑筱萸 . 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社,2002: 58
[6] Society of Respiratory Diseases, Chinese Medical Association . Guidelines for the diagnosis and treatment of community-acquired pneumonia[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2006,29(10):651-655
doi: 10.3321/j.issn:1671-167X.2006.03.012
中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南[J]. 中华结核和呼吸杂志, 2006,29(10):651-655
doi: 10.3321/j.issn:1671-167X.2006.03.012
[7] Mao B, Wang G, Fan T, Chen XD, Liu J, Wang L, Chang J, Ma JX, Guo J, Fu JJ, Li TQ . Assessing the quality of reporting of randomized controlled trials in traditional Chinese medicine[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2007,7(12):880-887
毛兵, 王刚, 樊涛, 陈小东, 刘佳, 王蕾, 常静, 马建昕, 郭佳, 付娟娟, 李廷谦 . 中医药随机对照试验报告质量评价[J]. 中国循证医学杂志, 2007,7(12):880-887
[8] Feng B, Liu J, Zhao XQ . Efficacy of Tanreqing injection in the treatment of 56 patients with community acquired pneumonia[J]. Zhongguo Xin Yao Za Zhi, 2008,17(5):418-419
冯柏, 刘晶, 赵学群 . 痰热清注射液结合抗生素治疗社区获得性肺炎56例[J]. 中国新药杂志, 2008,17(5):418-419
[9] Jiu T . Clinical efficacy of Tanreqing Injection and azithromycin in treating community-acquired pneumonia[J]. Zhongguo Shi Yong Yi Yao, 2007,2(15):107-108
久太 . 痰热清联合阿奇霉素治疗社区获得性肺炎疗效观察[J]. 中国实用医药, 2007,2(15):107-108
[10] Wen R, Tian J . Clinical observation of Tanreqing Injection and cephalosporins in treating community-acquired pneumonia[J]. Zhong Yi Yao Xue Kan, 2006,24(2):374-375
闻锐, 田军 . 痰热清联合头孢治疗社区获得性肺炎临床观察[J]. 中医药学刊, 2006,24(2):374-375
[11] Chen YF, Liu H, Hu XY .Clinical observation of Tanreqing Injection in treating aged community-acquired pneumonia[J].Zhongguo Zhong Yi Ji Zheng, 2006, 15(6): 575, 587
陈云凤, 刘洪, 扈晓宇 .痰热清治疗老年社区获得性肺炎临床观察[J].中国中医急症, 2006, 15(6): 575, 587
[12] Qu F . Clinical efficacy of Tanreqing Injection and antibiotics in treating community-acquired pneumonia[J]. Zhongguo Zhong Yi Ji Zheng, 2007,16(2):154-155
曲凡 . 痰热清注射液联合抗生素治疗社区获得性肺炎疗效观察[J]. 中国中医急症, 2007,16(2):154-155
[13] Zhang LY .Clinical efficacy of Tanreqing Injection and levofloxacin in treating community-acquired pneumonia[J].Zhongguo Zhong Yi Ji Zheng, 2007, 16(7): 774, 799
张理云 .痰热清注射液联合左氧氟沙星治疗社区获得性肺炎疗效观察[J].中国中医急症, 2007, 16(7): 774, 799
[14] Liu M .Clinical efficacy of Tanreqing Injection in treating mild to moderate community acquired pneumonia[J].Zhongguo Zhong Yi Ji Zheng, 2007, 16(7): 774, 799
刘梅 . 痰热清注射液治疗轻、中症社区获得性肺炎疗效观察[J]. 中国中医急症, 2007,16(9):1060-1061
[15] Liu JB, Sun ZJ, Zhang W . Treatment of community acquired pneumonia by Tanreqing Injectin: a clinical observation of 50 cases[J]. Xin Zhong Yi, 2006,38(3):27-29
刘建博, 孙志佳, 张伟 . 痰热清注射液治疗社区获得性肺炎50例疗效观察[J]. 新中医, 2006,38(3):27-29
[16] Yang G . Clinical efficacy of Tanreqing Injection in treating community-acquired pneumonia[J]. Shi Zhen Guo Yi Guo Yao, 2007,18(8):2017-2018
杨罡 . 痰热清注射液治疗社区获得性肺炎疗效研究[J]. 时珍国医国药, 2007,18(8):2017-2018
[17] Song YY, Li SG, Tian ZJ . Clinical efficacy of integrated traditional Chinese and Western medicine therapy in treating allergic diajournal patients with community-acquired pneumonia[J]. Hubei Zhong Yi Za Zhi, 2008,30(2):35-36
宋远瑛, 李树岗, 田正鉴 . 中西医结合治疗过敏体质人群社区获得性肺炎疗效观察[J]. 湖北中医杂志, 2008,30(2):35-36
[18] Li GQ, Bian YJ, Li GX, Li H, Liu ZG, Jin ZY, Liu JL . Efficacy of Tanreqing injection combined with antibiotics for the treatment of patients with acute bacterial pneumonia[J]. Zhongguo Xin Yao Za Zhi, 2008,17(6):509-511
李国勤, 边永君, 李光熙, 李辉, 刘志国, 金在艳, 刘俊玲 . 痰热清结合抗生素治疗急性细菌性肺炎50例[J]. 中国新药杂志, 2008,17(6):509-511
[19] Yan J, Rong XF, Ren QL, Shang XC .Clinical observation of Tanreqing Injection in treating aged patients with community-acquired pneumonia[J].Zhongguo Zhong Yi Ji Zheng, 2006, 15(7): 698, 729
严瑾, 荣晓凤, 任庆兰, 尚晓春 .痰热清注射液治疗老年社区获得性肺炎临床观察[J].中国中医急症, 2006, 15(7): 698, 729
[1] Jia Xu, Fu-qing Zhang, Jian Pei, Jun Ji . Acupuncture for migraine without aura: A systematic review and meta-analysis. Journal of Integrative Medicine, 2018, 16(5): 312-321.
[2] Qian-wen Ma, Yong Tan. Effectiveness of co-treatment with traditional Chinese medicine and letrozole for polycystic ovary syndrome: A meta-analysis. Journal of Integrative Medicine, 2017, 15(2): 95-101.
[3] Maria T.Chao, AlexandraChang, SanjayReddy, James D.Harrison, JosephAcquah, MiriaToveg, TrilceSantana, Frederick M.Hecht. Adjunctive acupuncture for pain and symptom management in the inpatient setting: Protocol for a pilot hybrid effectiveness-implementation study. Journal of Integrative Medicine, 2016, 14(3): 228-238.
[4] Nouran A. Aleyeidi, Khaled S. Aseri, Shadia M. Matbouli, Albaraa A. Sulaiamani, Sumayyah A. Kobeisy. Effects of wet-cupping on blood pressure in hypertensive patients: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(6): 391-399.
[5] Heather Ann Hausenblas, Kacey Heekin, Heather Lee Mutchie, Stephen Antonb. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. Journal of Integrative Medicine, 2015, 13(4): 231-240.
[6] Sung Min Lim, Sook-Hyun Lee. Effectiveness of bee venom acupuncture in alleviating post-stroke shoulder pain: A systematic review and meta-analysis. Journal of Integrative Medicine, 2015, 13(4): 241-247.
[7] Zhong-liang Liu, Wei-rong Zhu, Wen-chao Zhou, Hai-feng Ying, Lan Zheng, Yuan-biao Guo, Jing-xian Chen, Xiao-heng Shen. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. Journal of Integrative Medicine, 2014, 12(4): 346-358.
[8] Zhi-yi Zhou, Ling Xu, He-gen Li, Jian-hui Tian, Li-jing Jiao, Sheng-fu You, Zhi-fen Han, Yi Jiang, Hui-ru Guo​, Hui Liu​. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial. Journal of Integrative Medicine, 2014, 12(3): 175-181.
[9] Heather Ann Hausenblas, Debbie Saha, Pamela Jean Dubyak, Stephen Douglas Anton. Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Chinese Integrative Medicine, 2013, 11(6): 377-383.
[10] Jian Liu, Chuan-bing Huang, Yuan Wang, Gui-qin Xu, Yuan-yuan Cheng, Yun-xia Feng, Lei Liu, Ya-jun Qi. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: Study protocol of a multicenter randomized controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(6): 428-434.
[11] Tian-zhan Wang, Yu Chen, Yan-ming He, Xiao-dong Fu, Wang Yi, Yan-qiu Xu, Hong-jie Yang, Hong-li Xue, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(3): 175-183.
[12] Chung-wah Cheng, Shu-fei Fu, Qing-hui Zhou, Tai-xiang Wu, Hong-cai Shang, Xu-dong Tang, Zhi-shun Liu, Jia Liu, Zhi-xiu Lin, Lixing Lao, Ai-ping Lü, Bo-li Zhang, Bao-yan Liu, Zhao-xiang Bian. Extending the CONSORT Statement to moxibustion. Journal of Chinese Integrative Medicine, 2013, 11(1): 54-63.
[13] Hui Luo, Jian-ping Liu, Qing Li. Methodological issues and suggestions for improvement in randomized controlled trials of Chinese herbal medicine for recurrent miscarriage. Journal of Chinese Integrative Medicine, 2012, 10(6): 604-614.
[14] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[15] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
Full text



[1] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[7] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[10] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013